NCT02639741

Brief Summary

The investigators designed a randomized double-blind placebo-controlled trial to evaluate the effect of preoperative single dose of oral melatonin and vitamin C administration on postoperative analgesia in patients undergoing elective major abdominal surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for phase_4 postoperative-pain

Timeline
Completed

Started Nov 2014

Longer than P75 for phase_4 postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

November 11, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 24, 2015

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

August 9, 2021

Status Verified

August 1, 2021

Enrollment Period

5.2 years

First QC Date

November 11, 2015

Last Update Submit

August 6, 2021

Conditions

Keywords

MelatoninVitamin CMorphine consumption

Outcome Measures

Primary Outcomes (1)

  • morphine consumption at 24 hours after surgery.)

    24 hour

Study Arms (3)

Oral Melatonin Tablet

ACTIVE COMPARATOR

Melatonin, Vitamin C and placebo tablet Preoperative single oral dose of melatonin (6 mg) or placebo tablet will be given one hour before the start of anesthesia.

Drug: MelatoninDrug: Vitamin COther: Placebo

Oral Vitamin C Tablet

ACTIVE COMPARATOR

Melatonin, Vitamin C and placebo tablet Preoperative single oral dose of vitamin C (2 gr) or placebo tablet will be given one hour before the start of anesthesia.

Drug: MelatoninDrug: Vitamin COther: Placebo

Oral Placebo Tablet

PLACEBO COMPARATOR

Preoperative single oral dose of placebo tablet will be given one hour before the start of anesthesia.

Drug: MelatoninDrug: Vitamin COther: Placebo

Interventions

Preoperative melatonin tablet will be given and postoperative pain scores will be evaluated

Also known as: Melatonina 3 mg tb,
Oral Melatonin TabletOral Placebo TabletOral Vitamin C Tablet

Preoperative vitamin C tablet will be given and postoperative pain scores will be evaluated

Also known as: Vitamin C 1000 mg tb
Oral Melatonin TabletOral Placebo TabletOral Vitamin C Tablet
PlaceboOTHER

Preoperative placebo tablet will be given and postoperative pain scores will be evaluated

Also known as: Placebo tb
Oral Melatonin TabletOral Placebo TabletOral Vitamin C Tablet

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing elective major abdominal surgery with general anesthesia

You may not qualify if:

  • A history of psychiatric disorders, chronic pain syndromes, obstructive sleep apnea, severe asthma, chronic obstructive pulmonary disease, congestive heart failure, hepatic or renal failure, patients with pregnancy or in lactation period or a history of allergic reaction to any drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hakkı Ünlügenç

Adana, 01330, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

MelatoninAscorbic Acid

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

TryptaminesIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsHormonesHormones, Hormone Substitutes, and Hormone AntagonistsSugar AcidsAcids, AcyclicCarboxylic AcidsOrganic ChemicalsHydroxy AcidsCarbohydrates

Study Officials

  • Hakkı Ünlügenç, Prof Dr.

    Cukurova University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

November 11, 2015

First Posted

December 24, 2015

Study Start

November 1, 2014

Primary Completion

January 1, 2020

Study Completion

December 30, 2020

Last Updated

August 9, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations